初创企业s with brilliant technologies and potential have gathered in 松岛 International City, 仁川. This is the story of '仁川创业园区,' a public-private cooperation project to create a 初创企业 ecosystem known as the '韩国 Silicon Valley.' The publicly-led 'POOM' program, overseen by the 仁川经济自由区厅 and 仁川科技园, operates in the InSta I space. In InSta II, the privately-led 'S² Bridge: 仁川' (新韩Square Bridge 仁川) platform, driven by 新韩金融集团 (Chairman Yongbyung Jo) and Celltrion, supports the growth of 初创企业s. We met CEO Yongho Kim of 'RudaCure,' a publicly-nurtured company in InSta I, at 仁川创业园区 in 松岛.
RudaCure is a bio-healthcare specialist company developing new drug substances, a 'young venture' that launched in 2018. The company focuses on addressing '未满足的需求' in existing treatments.
One of the representative 管线s is the 干眼症治疗药.
RudaCure paid attention to 干眼症, which has a high domestic prevalence. Currently,